Lawrence Blatt
North America, California, United States
Description
Lawrence M. Blatt is the chief executive officer of Aligos Therapeutics. Lawrence M. Blatt attended University of La Verne.
Investor Profile
Lawrence Blatt has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
